A B S T R A C T The cellular location and carbohydrate specificities of a glycoprotein recognition system on rat hepatic sinusoidal cells have been determined. Purified preparations of endothelial, Kupffer, and parenchymal cells were prepared by collagenase liver perfusion, centrifugation on Percoll gradients, and centrifugal elutriation. '251-labeled agalactoorosomucoid, an N-acetylglucosamine-terminated glycoprotein, was selectively taken up in vitro by endothelial cells. Uptake was shown to be protein dependent, calcium ion dependent, and saturable, and could be described by Michaelis-Menten kinetics (apparent Km 0.29 ,M; apparent maximum velocity 4.8 pmol/h per 5 X 106 cells). Uptake was inhibited not only by Nacetylglucosamine, mannose, and mannan but also by glucose, fructose, and a glucose-albumin conjugate. Inhibition by glucose was competitive over a wide range of concentrations and was almost 100% at a glucose concentration of 56 mM. Fasting and the induction of diabetes mellitus prior to isolation of cells was associated with 60% reductions in the recovery of endothelial cells. Uptake by cells isolated from fasted rats was enhanced (apparent maximum velocity 14.3 pmol/ h per 5 X 10 cells without change in the apparent K.).
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These observations suggest that fasting is associated with a marked increase in the mean number of glycoprotein receptors per endothelial cell isolated from normal rats. This effect of fasting could be due to upregulation of glycoprotein receptors on endothelial cells or to the selective isolation of a subpopulation of endothelial cells from fasted animals that bears more glycoprotein receptors per cell than does another subDr. Summerfield's present address is Department of Medicine, Royal Free Hospital, London, England. Address reprint requests to Dr. Jones. INTRODUCTION The survival of glycoproteins in the circulation is critically influenced by the terminal nonreducing sugar residue of their oligosaccharide moiety (1) . Mannose- and N-acetylglucosamine-terminated glycoproteins are cleared by the liver (2) (3) (4) (5) (6) (7) and their removal is mediated by cells that line the hepatic sinusoids (8) (9) (10) (11) (12) (13) (14) . The site of the mannose/N-acetylglucosamine glycoprotein recognition system has been alternately ascribed to either Kupffer (8, 10, 14) or endothelial cells (11) . In this paper we provide evidence from studies of isolated rat hepatic cells that the mannose/N-acetylglucosamine receptor is present on hepatic endothelial cells. We also show that the ability of this receptor on endothelial cells to mediate the uptake of a specific ligand is potently inhibited in vitro by glucose and a glucose-albumin conjugate.
Nuclear (Boston, MA) and Na36Cl from Amersham-Searle (Arlington Heights, IL). Ultrafluor scintillation fluid was obtained from National Diagnostics (Somerville, NJ). Rabbit anti-whole sheep erythrocyte antibodies (7 and 19S) were obtained from Cordis Laboratories (Miami, FL). Sheep erythrocytes (E) were provided by the National Institutes of Health Animal Production Section. Pure undenatured human asialoorosomucoid (ASOR) and agalactoorosomucoid (AGOR) were generous gifts from Dr. Gilbert Ashwell. Orosomucoid had been isolated from normal human plasma and its terminal nonreducing carbohydrate residues had been modified by incubation with purified neuraminidase (to yield ASOR) or neuraminidase followed by purified #-Dgalactosidase (to yield AGOR) (15) . A neoglycoprotein, glucose-albumin conjugate (bovine serum albumin) was a gift from Dr. Y. C. Lee. It contained -35 mol of glucose/mol albumin (16) .
Iodination of glycoproteins. The procedure used to radioiodinate glycoproteins was the Bio-Rad Laboratories (Richmond, CA) solid-phase Enzymobead system, which uses immobilized lactoperoxidase and glucose oxidase. Re- 25 ul of 1% ,-D-glucose, 50 ul of 1.0 M pH 6.8 phosphate buffer, and 10 Ml of aqueous Nal2"I containing a total of 1 mCi. The reaction was stopped by passing the mixture through G-25 Sephadex column (1.5 X 5 cm). The labeled protein was collected free of nonbound 1251 Animals. Male Sprague-Dawley rats (250-350 g) were purchased from Taconic Farms (Germantown, NY). Fed rats were allowed Purina rat chow (Ralston-Purina Co., St. Louis, MO) and water ad lib. Fasted rats were deprived of food for 24 h before liver cell isolation but were permitted unrestricted access to water. Diabetes mellitus was induced by the intravenous or intraperitoneal injection of streptozotocin (80 mg/kg in 0.09 M NaCl, 0.01 M citrate buffer, pH 3.5). Liver cell isolation was performed 4 d after streptozotocin administration. Blood glucose estimations were performed on blood collected into fluoride tubes by Litton Bionetics (Kensington, MD).
Liver perfusion. Animals were anesthetized with ether.
Heparin was not used. Livers were perfused in situ using standard techniques (17, 18 (19) . The collagenase solution was recirculated for 30 min, and maintained at pH 7.4 by adding 1 M NaOH as required using phenol red as indicator. The resulting whole liver suspensions were dispersed in a further 50 ml of the collagenase solution to which deoxyribonuclease (0.0005% wt/vol) had been added and agitated in a water bath at 370C for 10 min. Deoxyribonuclease (0.0005% wt/ vol), which inhibits aggregation of cells in cell suspensions (20) , was added to the buffer used in all subsequent steps of the isolation procedure. The cell suspension was filtered through 0.5-mm and 100-ym nylon sieves and the debris washed. The suspension was then made up to 100 ml before centrifugation at 20 g for 2 min at 21°C. The supernatant was decanted and the pellet resuspended in HBSS. This sequence of procedures was repeated twice. The final pellet consisting of parenchymal cells was resuspended in HBSS. The supernatants were also centrifuged twice more at 20 g for 2 min to remove contaminating parenchymal cells and were then centrifuged at 600 g for 7 min to yield a pellet containing nonparenchymal cells and some erythrocytes. Viability of cells was assessed by two independent methods. Trypan blue exclusion was 280% for parenchymal cell enriched fractions and 290% for nonparenchymal cell enriched fractions. The membrane potential of isolated cells measured by the method described by Baur et al. (21) , was -33±1.2 mV (mean±SEM, n = 12).
Cell purification on Percoll gradients. Density gradients of Percoll were selected for purification of the cell fractions because of the low toxicity of this medium (22, 23) . The method adopted was as follows: Waymouth's medium dry powder (amount for 1 liter) was dissolved in 333 ml water and filtered through a 0.45-,um filter (Nalgene, Industrial Div. Nalge Co., Div. Sybron Corp., Rochester, NY). This solution was mixed with 667 ml Percoll and stored at 4°C. Before use deoxyribonuclease (0.0005% wt/vol) was added and the Percoll mixture gassed with 90% 02:5% CO2. The density gradients were generated by centrifuging 30-ml aliquots of the mixture in an SW 27 rotor in an L5-50 ultracentrifuge (Beckman Instruments, Inc., Palo Alto, CA) at 60,000 g for 1 h at 15°C. Suspensions of cells were layered on top of the gradients and centrifuged at 800 g for 15 min at 15°C. Using density marker beads, both endothelial and Kupffer cells were found to form a band at a density of 1.062 and parenchymal cells at a density of 1.097. As the two bands were located -4 cm apart in the gradients, a clear separation of parenchymal and nonparenchymal cells was achieved. Cell debris and damaged cells settled at the top of the gradient (d, 1.033-1.048). The cells were recovered by aspirating separately each of the layers containing cells, diluting them 1:4 with HBSS and centrifuging the parenchymal cell fraction at 50 g for 2 min and the nonparenchymal cell fraction at 600 g for 7 min. Trypan blue exclusion was 295% for the parenchymal and nonparenchymal cells recovered from Percoll gradients.
Centrifugal elutriation. Centrifugal elutriation was used to separate endothelial from Kupffer cells (24, 25) . The nonparenchymal cells, suspended in HBSS (8 ml), were loaded into a Beckman JE6-B elutriator rotor in a J2-21 centrifuge at 15°C. Elutriation was carried out at a rotor speed of 2,555 rpm. The rotor was initially eluted with HBSS at a flow rate of 11 ml/min. At this flow rate 150 ml buffer were collected and discarded to remove debris and lymphocytes. The flow rate was increased to 21 ml/min and 100 ml buffer collected. This fraction contained predominantly endothelial cells. The flow rate was increased to 42 ml/min and a further 100-ml buffer was collected. This fraction contained predominantly Kupffer cells. The cells were recovered by centrifuging the eluates at 600 g for 7 (27) . Cathepsin B1 (EC 3.4.4.-) was estimated using a-N-benzyloxycarbonyl-L-lysine-p-nitrophenyl ester-HCI (28 30 s. The cell pellet in the KOH layer was removed by slicing through the silicone oil layer and radioactivity in the pellet measured using a Nuclear Chicago gamma counter (Nuclear Chicago Corp., Des Plaines, IL). Acid precipitable radioactivity in the microfuge tube supernatant was also determined by adding to 200 ul of the supernate horse serum (800 Ml) and 25% (wt/ vol) trichloroacetic acid (1 ml), centrifuging at 3,500 g for 7 min, and measuring the radioactivity in the supernate and pellet. Specific uptake of '25I-AGOR by cells was estimated by subtracting its uptake in the presence of the inhibitor mannan (100 Mg/ml), a polysaccharide of mannose, from that in the absence of inhibitor. In all experiments nonspecific uptake accounted for <20% of maximal uptake.
In vivo studies. A tracer dose of '25I-AGOR (-2 Mg; 5 X 106 cpm) was injected under ether anesthesia into a femoral vein. Blood samples (0.5 ml) were obtained by repeated cardiac puncture during the subsequent 0.5-7 min. The liver, spleen, and left kidney were then rapidly removed and their radioactivity content estimated. The blood disappearance curve of 125I-AGOR was defined by determining the best fit of experimental measurements of blood acid precipitable radioactivity to the sum of exponential functions using a DEC 10 computer. From the parameters of the fitted curve the percentages of the initial radioactivity remaining in the blood at seven successive 1-min intervals after the injection of 1251-AGOR were calculated. The mean of values for protein-bound radioactivity (±SEM) at each of these selected times was calculated for each different experimental group (see below). To determine the fractional disappearance rate of '251-AGOR from blood the fitted blood radioactivity curves were normalized so that the sum of the coefficients of the exponentials equalled unity. The fractional disap- Effect of streptozotocin-induced diabetes mellitus on isolated cell populations Diabetes mellitus was associated with a reduction in the mean yield of endothelial cells (100±9 X 10' cells), the yield of these cells being similar to that obtained from fasted normal rats. The recoveries of Kupffer cells (52±3 X 10' cells) and parenchymal cells (337±32 X 10' cells) from diabetic rats were similar to corresponding recoveries from fed normal rats. Consequently, the total yield of hepatic cells from diabetic animals (490±36 X 106 cells) was -100 X 10' cells less than that from fed normal rats. This difference was accounted for by the lower recovery of endothelial cells (-98 X 106 fewer) from diabetic rats. In diabetic animals a 24-h fast was not associated with any appreciable further changes in the recoveries of different cells.
Uptake of glycoproteins by hepatic cells
Uptake of '25I-AGOR by hepatic cells from fed and fasted rats. The uptake of '25l-AGOR (N-acetylglucosamine-terminated) by cells in preparations of endothelial cells and Kupffer cells from fed rats was timedependent at 37°C (Fig. 1) Table  II summarizes data on the inhibition of endothelial cell uptake of 125I-AGOR by a variety of compounds. Uptake was inhibited by the monosaccharides, N-acetylglucosamine, glucose, mannose, and fructose. Uptake was also inhibited by the glycoproteins agalactoorosomucoid (N-acetylglucosamine-terminated) and the glucose-albumin conjugate and by the polysaccharide of mannose, mannan, but it was not inhibited by the glycoprotein asialoorosomucoid (galactose-terminated). Uptake was partially inhibited by ovalbumin, a mannose-terminated glycoprotein that exhibits microheterogeneity (38) . The uptake of '25I-AGOR by endothelial cells was abolished in the presence of EDTA indicating that this uptake process has an absolute requirement for calcium ions. Furthermore, the uptake of '25I-AGOR by endothelial cells at 0°C (assumed to be due to binding only) was less than that at 370C (Table II) and no catabolism of 1251-AGOR (accumulation of acid-precipitable radioactivity in the incubation medium) was observed at 0°C. These observations imply that at 370C both binding and internalization of 1251-AGOR by endothelial cells occur. Effect of streptozotocin-induced diabetes mellitus Inhibition was expressed as the percentage reduction of the initial uptake velocity of issI-AGOR (500 ng/ml) by an inhibitor. '25I-AGOR was incubated with endothelial cells in the presence and absence of inhibitors at 370C. These results are representative of two other similar experiments. The initial uptake velocity was calculated from a least-squares fit of the uptake data at 2, 5, 10, and 20 min after addition of the labeled ligand.
on the uptake of 125I-AGOR by endothelial cells. In view of the marked inhibition of the endothelial cell uptake of 1251-AGOR by glucose and the observation that fasted animals not only had a lower blood glucose concentration (120±3 mg/dl; n = 11) than fed animals (138±5 mg/dl; n = 6) but also exhibited augmented uptake of '25I-AGOR by isolated endothelial cells, experiments were designed to determine whether hyperglycemia influenced the enhancement of 1251-AGOR uptake induced by fasting. Endothelial cells were isolated from rats with streptozotocin-induced diabetes mellitus. Some diabetic rats were fasted for 24 h before isolation of the cells. The blood glucose concentration in fed diabetic rats was 517±44 mg/dl (n = 8) and in fasted diabetic rats was 323±29 mg/dl (n = 5). The uptake of 125I-AGOR by endothelial cells, isolated from fed diabetic rats (in glucose-free HBSS) was similar to that by cells isolated from fed normal rats. Furthermore, in diabetic rats fasting did not result in enhancement of endothelial cell uptake of 125I-AGOR. Thus, the apparent maximum velocity (4.8 pmol/h per 5 X 106 cells) and the apparent Km (0.29 AM) for 12511
AGOR uptake by endothelial cells isolated from both fed and fasted diabetic animals were similar to the corresponding values obtained for normal fed rats.
In vivo metabolism of 125I-AGOR. The in vivo metabolism of 125I-AGOR was studied in groups of fed, fasted, and diabetic rats. The sum of two exponential functions was found to be both necessary and sufficient to define the plasma disappearance curves of intravenously administered '25I-AGOR. Apparent initial volume of distributions of 125I-AGOR (-25 ml) approximated to the blood volume (39) and were similar in fed, fasted and diabetic rats (Table III) . The plasma disappearance of 125I-AGOR (Fig. 6 ) in fed rats was rapid. In fasted rats, the mean plasma disappearance was more rapid. However, the mean fractional disappearance rates for fed and fasted animals were not significantly different (Table III) . In both fed and fasted animals, 7 min after injection of 125I-AGOR -66% of the administered radioactivity had accumulated in the liver and <2% was found in the spleen or kidney. By 7 min -12% of the administered 1251_ AGOR had been catabolized, as determined by accumulation of acid soluble radioactivity in blood. In contrast, in diabetic animals (blood glucose concentration 438±12 mg/dl) the fractional plasma disappearance rate, hepatic accumulation (51%), and catabolism (4.3%) of 125I-AGOR were all less than in either fed or fasted normal rats (Table III) . DISCUSSION Isolation of hepatic cells. The objectives of the cell isolation procedures used in this study were to prepare Modulation of Glycoprotein Recognition System on Rat Hepatic Endothelial Cells (43) (44) (45) so that is is possible that the reduced recovery of sinusoidal cells is attributable to stronger cell-cell interactions between sinusoidal and parenchymal cells after fasting.
Streptozotocin (2-deoxy-2-[3-methyl-3-nitrosourea]-D-glucopyranose) is believed to be a relatively specific toxin for pancreatic beta cells (for reviews see 46, 47) . It has been suggested that the glucose moiety of the streptozotocin molecule mediates its specific recognition and uptake by pancreatic beta cells. In support of this hypothesis are the observations that the diabetogenic effectiveness of streptozotocin is reduced by removal of the glucose moiety or its substitution by galactose or by the administration of certain monosaccharides such as glucose, 3-0-methyl glucose and 2-deoxyglucose (47) . In view of the findings in this study that show that the mannose/N-acetylglucosamine receptors on endothelial cells also possess specificities for glucose and glucose-terminated glycoproteins (discussed below), it is possible that the reduced recovery of endothelial cells from streptozotocintreated rats is due to a direct toxic effect of streptozotocin on these cells. Such an effect could have important implications for investigations of lipid meta-bolism and the vascular complications of diabetes mellitus using the streptozotocin animal model. An alternative explanation, that diabetes mellitus has a direct effect on endothelial cell recovery, cannot be discounted.
Uptake of glycoproteins by hepatic cells. This study has confirmed previous observations that 125I1 AGOR, an N-acetylglucosamine-terminated glycoprotein, is rapidly cleared from plasma by the liver (2) (3) (4) (5) (6) (7) 9) . It is possible that the receptor that mediates this clearance process and a mannan-binding protein, which has been isolated from whole liver (48) , are identical. This study has also confirmed that, in contrast to galactose-terminated glycoproteins (12), the hepatic clearance of '25I-AGOR is mediated by sinusoidal cells and not parenchymal cells (8, 10, 12, 13) . On the basis of extrapolations from circumstantial evidence (14, 49) it has been presumed that the mannose/ N-acetylglucosamine receptor is located on Kupffer cells. However, the only previous study to have directly addressed the question of the localization of the mannose/N-acetylglucosamine receptor indicated that it was present principally on hepatic endothelial cells (11) . In that study, which used both autoradiography and electron microscopy, the label of intravenously injected '251-labeled mannose and N-acetylglucosamine-terminated glycoproteins was shown to accumulate selectively in hepatic sinusoidal cells and endothelial cells were found to internalize two to six times more radioactivity (on a cell volume basis) than Kupffer cells. Our in vitro data clearly indicate that the mannose/N-acetylglucosamine receptor is located on hepatic endothelial cells and that AGOR not only binds to this receptor but is also internalized by these cells.
This study has confirmed the previously reported dual specificity of the receptor for glycoproteins on hepatic sinusoidal cells (13) . However, uptake of AGOR by endothelial cells was not only inhibited by N-acetylglucosamine and mannose, but also by glucose and its isomer fructose, indicating that the mannose/ N-acetylglucosamine receptor possesses additional specificities. The failure of previous studies to detect inhibition of sinusoidal cell uptake of AGOR by glucose is probably attributable to either administering too little glucose during in vivo studies (8) or to performing in vitro experiments in a medium containing high concentrations (500 mg/dl) of glucose (13) . The results of this study indicate that glucose competitively inhibits the uptake of AGOR by the mannose/N-acetylglucosamine receptor over a concentration range of two orders of magnitude that includes both physiological and pathological concentrations. In the presence of high glucose concentrations, similar to those that may occur in plasma in diabetes mellitus, almost complete inhibition of the uptake of AGOR by endothelial cells was observed. It is noteworthy that a glucose-terminated glycoprotein (glucose-albumin conjugate) was about six orders of magnitude more potent an inhibitor of the uptake of AGOR by endothelial cells than glucose alone. In other carbohydratemediated glycoprotein recognition systems similar differences in the potency of glycoproteins and relevant simple sugars alone in inhibiting the binding of a specific ligand are well recognized (50) . Glucose has also been shown to inhibit the binding of an N-acetylglucosamine-bovine serum albumin conjugate to the mannose/N-acetylglucosamine receptor in vitro (51) . The inhibition of the endothelial cell uptake of AGOR by fructose is of particular interest because a fructose residue is the terminal sugar of spontaneously glycosylated proteins such as hemoglobin A1c and glycosylated albumin. The terminal fructose residue of such glycoproteins is generated by an Amadori rearrangement of the Schiff base formed between the free amino groups of the protein and glucose (52) . However, the capacity of glycoproteins, such as the glucose-albumin conjugate, to inhibit the uptake of specific ligands by glycoprotein recognition systems depends largely on the degree of substitution of the protein with sugar residues (53) . At present, there is no evidence that sufficient glycosylation of proteins occurs in diabetes mellitus to mediate uptake of glycosylated proteins by endothelial cells. Conversely, the accumulation of glycosylated proteins in plasma in diabetes mellitus (54) could be due, at least in part, to hyperglycemia inhibiting their uptake by hepatic endothelial cells.
The interpretation of the results of the in vitro experiments is complicated by the variations in endothelial cell yield in the different experimental groups. Although fasting was associated with a threefold increase in the uptake of 125I-AGOR by endothelial cells without any change in the affinity of the receptor on these cells, the yield of endothelial cells from fasted animals was almost three times lower than that from fed rats. Two interpretations of these findings are possible. First, the observed augmented uptake of AGOR could be due to a fasting-induced up-regulation of mannose/N-acetylglucosamine receptors on endothelial cells. Second, a subpopulation of endothelial cells enriched with these receptors may have been selectively isolated from fasted animals. This second possibility tends to be favored by the observation that the plasma disappearance and hepatic accumulation of 1251-AGOR in vivo were similar in fed and fasted animals.
The results of the in vitro experiments indicated that the induction of diabetes mellitus did not influence the uptake of '25I-AGOR by isolated endothelial cells in a glucose-free medium and, in contrast to the data Modulation of Glycoprotein Recognition System on Rat Hepatic Endothelial Cells obtained from normal animals, that prior fasting of diabetic animals did not augment the uptake of this ligand by isolated endothelial cells. Potential explanations of the latter finding include an abolition of fasting-induced up-regulation of the mannose/N-acetylglucosamine receptor due to hyperglycemia or some other effect of diabetes mellitus and a direct toxic effect of streptozotocin on a subpopulation of endothelial cells enriched with mannose/N-acetylglucosamine receptors (see above). As it is uncertain whether streptozotocin is toxic to hepatic endothelial cells caution is necessary in the interpretation of the decreased clearance from plasma, hepatic accumulation, and catabolism of '251-AGOR observed in diabetic animals. However, it has been shown that the clearance of an N-acetylglucosamine-bovine serum albumin conjugate from plasma in mice is diminished if diabetes mellitus is induced using alloxan, and that this phenomenon also occurs if hyperglycemia is induced in the absence of diabetes mellitus (51) .
In conclusion, this study has demonstrated that a specific carbohydrate-mediated glycoprotein recognition system is present on hepatic endothelial cells. Thus, these cells appear to possess functional specialization in addition to their morphological specializations such as sieve plates (43) . We have also shown that the receptor-mediated uptake by endothelial cells of a glycoprotein terminating in N-acetylglucosamine is markedly inhibited by glucose and by a glucose-albumin conjugate. Glucose and glycosylated proteininduced modulation of receptor-mediated pinocytosis of glycoproteins by vascular endothelial cells may contribute to abnormal metabolism of glycoproteins in diabetes mellitus.
